相关实验视频
Updated: Sep 13, 2025

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.5K
一种罕见的慢性淋巴细胞白血病病例,由肌痛性严重性肌痛症复杂化
Eiraj Khan1, Rimal Ilyas1, Shivani Shah1
1Department of Internal Medicine, Allegheny General Hospital, United States.
Journal of community hospital internal medicine perspectives
|August 4, 2025
概括
这一案例凸显了慢性淋巴细胞白血病 (CLL) 和耐火性骨髓灰质炎 (MG) 之间罕见的关联. 早期使用Rituximab等药物治疗CLL导致严重MG症状的解决.
科学领域:
- 血液学 血液学 血液学
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 自免疫并发症影响10-25%的慢性淋巴细胞白血病 (CLL) 患者.
- 在CLL中,非血液性自身免疫表现,包括肌痛性肌痛症 (MG) 是罕见的.
- 只有27个出版物报道了CLL-MG协会,涉及15个案例.
研究的目的:
- 在一个新诊断为慢性淋巴细胞白血病的患者中呈现一种耐火性肌痛性肌痛症的病例.
- 讨论这种罕见的同时发生的诊断和治疗含义.
- 强调及时干预对改善患者结果的重要性.
主要方法:
- 一名56岁的男性患有Rai II阶段的CLL和MG,出现呼吸困难和消化不良.
- 最初的治疗包括静脉注射的免疫球蛋白,皮里多斯提格和索卢梅德罗.
- 耐药性MG症状导致开始每周服用rituximab,随后服用obinutuzumab和venetoclax来治疗CLL.
主要成果:
- 患者在第一次Rituximab剂量后经历了食障碍的临床改善.
- 随着持续的CLL治疗,在几个月内观察到MG症状的逐渐消失.
- 这一案例强调了CLL治疗解决神经症状的潜力.
结论:
- 耐火性骨髓灰质炎可能是慢性淋巴细胞白血病的呈现或复杂的特征.
- 及时诊断和对CLL和MG的综合治疗对于管理这种罕见的关联至关重要.
- 有效管理CLL可以导致相关的神经症状的缓解,如MG.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Myasthenia Gravis: Diagnostic Tests
1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Chemical Synapses
9.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.1K
Muscle Contraction
7.0K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
7.0K
Disorders of Leukocytes
1.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.1K

